User:Lychee-coffee/COVID-19 vaccination in Mainland China
COVID-19 vaccination in Mainland China is an ongoing immunisation campaign against
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country
.
As of May 2021, six vaccines in Mainland China have been approved for conditional marketing or emergency use, and can be used for vaccination by vaccination units[1].
Vaccines on order
As of June 10, 2021, a total of 7 vaccines in Mainland China have been approved for conditional marketing or emergency use.
Early EUA Approved Vaccines
Vaccine | Vaccine Type | Manufacturer | Doses Required for Vaccination | Phase III clinical trial effective rate | Emergency Use Authorization | Deployment | Date of Listing in EUL by COVAX |
---|---|---|---|---|---|---|---|
Sinopharm (BBIBP-CorV)
|
Inactivated | Sinopharm (Beijing)
|
2[2] | 86%[3] | December 31, 2020 | December 31, 2020 | May 7, 2021 |
Sinovac (CoronaVac) | Inactivated | Sinovac | 2[2] | 50.4% - 83.5%[4][5][6] | February 5, 2021 | February 5, 2021 | June 1, 2021 |
Sinopharm (WIBP-CorV)
|
Inactivated | Sinopharm (Wuhan)
|
2[2] | 72.8%[7] | February 25, 2021 | February 25, 2021 | No |
CanSino (Convidecia) | Adenoviridae | CanSino | 1[2] | 65.7%[8] | February 25, 2021 | February 25, 2021 | No |
Anhui Zhifei (ZF2001)[9] | Protein subunit | Anhui Zhifei | 3[2] | [10] | March 10, 2021 | March 10, 2021 | No |
Others Vaccines Authorised after May 2021
Vaccine | Vaccine Type | Manufacturer | Doses Required for Vaccination | Emergency Use Authorization | Deployment |
---|---|---|---|---|---|
可维克 | Inactivated | 康泰生物 | 2 | 2021年05月14日批准紧急使用 | 2021年06月01日開始接種 |
科维福 | Inactivated | 中国医学科学院医学生物学研究所 | 2 | 2021年06月09日批准紧急使用 | 2021年06月09日開始接種 |
See also
Reference
- ^ "新冠病毒疫苗接种问答来了!涉及34个关键问题". 中国新闻网. 2021-04-01. Retrieved 2021-04-02.
- ^ a b c d e "新冠病毒疫苗接种问答来了!涉及34个关键问题". 中国新闻网. 2021-04-01. Retrieved 2021-04-02.
- ^ "National Health Regulatory Authority approves Sinopharm COVID-19 vaccine". BNA. 2020-12-13. Archived from the original on 2021-02-14. Retrieved 2021-02-14.
- ^ "Sinovac: Brazil results show Chinese vaccine 50.4% effective". BBC News. 2021-01-13. Archived from the original on 2021-03-10. Retrieved 2021-03-13.
- ^ "Turkey set to receive 'effective' COVID-19 vaccine amid calls for inoculation". Daily Sabah. 2020-12-25. Archived from the original on 2021-01-08. Retrieved 2021-03-13.
- ^ "Indonesia grants emergency use approval to Sinovac's vaccine, local trials show 65% efficacy". The Straits Times. 2021-01-11. Archived from the original on 2021-01-30. Retrieved 2021-03-13.
- ISSN 0098-7484.
- ^ "CanSinoBIO's COVID-19 vaccine 65.7% effective in global trials, Pakistan official says". Reuters. 2021-02-08. Retrieved 2021-02-08.
- ^ "智飞生物业绩看上去很美,但撑得起3000亿市值吗?". 界面新闻. 2021-04-20. Retrieved 2021-04-20.
- ^ "智飞生物冠病疫苗临床结果显示有效率达97%". 联合早报 (in Simplified Chinese). 2021-03-26. Retrieved 2021-04-03.